Medicine & Health

A new School of Medicine study indicates that people with dementia — whose parents also had dementia — develop symptoms an average of six years earlier than their parents.

Researchers at the School of Medicine have found that Enhanced Medical Rehabilitation, a type of goal-oriented therapy, helps older patients recover more fully than standard physical or occupational therapy. It involves focusing on specific goals important to individual patients and motivating patients to work toward those goals during every therapy session.

Researchers at the School of Medicine have shown that supplementing older mice with an enzyme from younger mice extends life spans in the older ones.

The School of Medicine has received a $15 million commitment from longtime benefactors Philip and Sima Needleman to support two cutting-edge research centers aimed at developing new treatments for diseases that collectively affect millions.

A new study from the School of Medicine finds that women’s brains appear to be about three years younger than men’s of the same chronological age, metabolically speaking. The findings could be one clue to why women tend to stay mentally sharp longer than men.

Scientists at the School of Medicine have identified a previously unknown route for cellular fuel delivery, a finding that could shed light on the process of aging and the chronic diseases that often accompany it.

New research at the School of Medicine suggests that aging immune cells increase the risk for age-related macular degeneration, a major cause of blindness in the United States.

Marylen Mann is the founder of OASIS a nationwide program to help seniors remain active and engaged in their communities even after retirement.

Scientists at the School of Medicine have shown that supplementing healthy mice with a natural compound called NMN can compensate for a loss of energy production in aging cells, reducing typical signs of aging such as gradual weight gain, loss of insulin sensitivity and declines in physical activity.

More than half of older adults with clinical depression don’t get better when treated with an antidepressant. But results from a multicenter clinical trial that included Washington University School of Medicine in St. Louis indicates that adding a second drug — an antipsychotic medication — to the treatment regimen helps many of those patients.